PathologybioRxiv
SOX2 expression identifies Ewing sarcoma patients with high risk for tumor relapse and poor survival
DOI 10.1016/j.ebiom.2019.08.002
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
2 papers
Recent·Most cited
M. Dallmayer, J. Li, S. Ohmura…·T. G. P. Grunewald
This study identifies CALCB as a direct EWSR1-FLI1 target in Ewing sarcoma and shows that targeting the CALCB/RAMP1-axis inhibits tumor growth.